世界の肝性脳症薬市場:販売動向2018

【英語タイトル】Global Hepatic Encephalopathy Drug Sales Market Report 2018

QYResearchが出版した調査資料(QYR8020832)・商品コード:QYR8020832
・発行会社(調査会社):QYResearch
・発行日:2017年12月29日
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥896,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポート(2018年版)では、肝性脳症薬の世界市場について調査・分析し、肝性脳症薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、肝性脳症薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・肝性脳症薬市場概要
・肝性脳症薬のメーカー別販売量・メーカー別シェア
・肝性脳症薬の世界市場:種類別販売量・市場シェア
・肝性脳症薬の世界市場:用途別販売量・市場シェア
・肝性脳症薬の世界市場:地域別販売量・市場シェア
・肝性脳症薬のアメリカ市場規模
・肝性脳症薬の中国市場規模
・肝性脳症薬のヨーロッパ市場規模
・肝性脳症薬の日本市場規模
・肝性脳症薬の東南アジア市場規模
・肝性脳症薬のインド市場規模
・肝性脳症薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・肝性脳症薬のコスト分析・価格動向
・肝性脳症薬の産業チェーン(サプライチェーン分析)
・肝性脳症薬のマーケティング戦略・販売チャネル、流通業者
・肝性脳症薬市場への影響要因分析
・肝性脳症薬の世界市場予測
・肝性脳症薬のアメリカ市場予測
・肝性脳症薬の中国市場予測
・肝性脳症薬のヨーロッパ市場予測
・肝性脳症薬の日本市場予測
・肝性脳症薬の東南アジア市場予測
・肝性脳症薬のインド市場予測
・肝性脳症薬の種類別世界市場予測
・肝性脳症薬の用途別世界市場予測
...
【レポートの概要】

In this report, the global Hepatic Encephalopathy Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Hepatic Encephalopathy Drug for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Hepatic Encephalopathy Drug market competition by top manufacturers/players, with Hepatic Encephalopathy Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Alfa Wassermann S.p.A
Cosmo Pharmaceuticals S.p.A
Horizon Pharma Plc
KannaLife Sciences, Inc.
Ocera Therapeutics, Inc.
Rebiotix Inc.
Spherium Biomed S.L.
Umecrine Cognition AB
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
RBX-2660
KLS-13019
GR-3027
SYNB-1020
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Clinic
Hospital
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Hepatic Encephalopathy Drug Sales Market Report 2017
1 Hepatic Encephalopathy Drug Market Overview
1.1 Product Overview and Scope of Hepatic Encephalopathy Drug
1.2 Classification of Hepatic Encephalopathy Drug by Product Category
1.2.1 Global Hepatic Encephalopathy Drug Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Hepatic Encephalopathy Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 RBX-2660
1.2.4 KLS-13019
1.2.5 GR-3027
1.2.6 SYNB-1020
1.2.7 Others
1.3 Global Hepatic Encephalopathy Drug Market by Application/End Users
1.3.1 Global Hepatic Encephalopathy Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Hepatic Encephalopathy Drug Market by Region
1.4.1 Global Hepatic Encephalopathy Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Hepatic Encephalopathy Drug Status and Prospect (2012-2022)
1.4.3 China Hepatic Encephalopathy Drug Status and Prospect (2012-2022)
1.4.4 Europe Hepatic Encephalopathy Drug Status and Prospect (2012-2022)
1.4.5 Japan Hepatic Encephalopathy Drug Status and Prospect (2012-2022)
1.4.6 Southeast Asia Hepatic Encephalopathy Drug Status and Prospect (2012-2022)
1.4.7 India Hepatic Encephalopathy Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Hepatic Encephalopathy Drug (2012-2022)
1.5.1 Global Hepatic Encephalopathy Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Hepatic Encephalopathy Drug Revenue and Growth Rate (2012-2022)

2 Global Hepatic Encephalopathy Drug Competition by Players/Suppliers, Type and Application
2.1 Global Hepatic Encephalopathy Drug Market Competition by Players/Suppliers
2.1.1 Global Hepatic Encephalopathy Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Hepatic Encephalopathy Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Hepatic Encephalopathy Drug (Volume and Value) by Type
2.2.1 Global Hepatic Encephalopathy Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Hepatic Encephalopathy Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Hepatic Encephalopathy Drug (Volume and Value) by Region
2.3.1 Global Hepatic Encephalopathy Drug Sales and Market Share by Region (2012-2017)
2.3.2 Global Hepatic Encephalopathy Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Hepatic Encephalopathy Drug (Volume) by Application

3 United States Hepatic Encephalopathy Drug (Volume, Value and Sales Price)
3.1 United States Hepatic Encephalopathy Drug Sales and Value (2012-2017)
3.1.1 United States Hepatic Encephalopathy Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Hepatic Encephalopathy Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Hepatic Encephalopathy Drug Sales Price Trend (2012-2017)
3.2 United States Hepatic Encephalopathy Drug Sales Volume and Market Share by Players
3.3 United States Hepatic Encephalopathy Drug Sales Volume and Market Share by Type
3.4 United States Hepatic Encephalopathy Drug Sales Volume and Market Share by Application

4 China Hepatic Encephalopathy Drug (Volume, Value and Sales Price)
4.1 China Hepatic Encephalopathy Drug Sales and Value (2012-2017)
4.1.1 China Hepatic Encephalopathy Drug Sales and Growth Rate (2012-2017)
4.1.2 China Hepatic Encephalopathy Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Hepatic Encephalopathy Drug Sales Price Trend (2012-2017)
4.2 China Hepatic Encephalopathy Drug Sales Volume and Market Share by Players
4.3 China Hepatic Encephalopathy Drug Sales Volume and Market Share by Type
4.4 China Hepatic Encephalopathy Drug Sales Volume and Market Share by Application

5 Europe Hepatic Encephalopathy Drug (Volume, Value and Sales Price)
5.1 Europe Hepatic Encephalopathy Drug Sales and Value (2012-2017)
5.1.1 Europe Hepatic Encephalopathy Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Hepatic Encephalopathy Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Hepatic Encephalopathy Drug Sales Price Trend (2012-2017)
5.2 Europe Hepatic Encephalopathy Drug Sales Volume and Market Share by Players
5.3 Europe Hepatic Encephalopathy Drug Sales Volume and Market Share by Type
5.4 Europe Hepatic Encephalopathy Drug Sales Volume and Market Share by Application

6 Japan Hepatic Encephalopathy Drug (Volume, Value and Sales Price)
6.1 Japan Hepatic Encephalopathy Drug Sales and Value (2012-2017)
6.1.1 Japan Hepatic Encephalopathy Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Hepatic Encephalopathy Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Hepatic Encephalopathy Drug Sales Price Trend (2012-2017)
6.2 Japan Hepatic Encephalopathy Drug Sales Volume and Market Share by Players
6.3 Japan Hepatic Encephalopathy Drug Sales Volume and Market Share by Type
6.4 Japan Hepatic Encephalopathy Drug Sales Volume and Market Share by Application

7 Southeast Asia Hepatic Encephalopathy Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Hepatic Encephalopathy Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Hepatic Encephalopathy Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Hepatic Encephalopathy Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Hepatic Encephalopathy Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Hepatic Encephalopathy Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Hepatic Encephalopathy Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Hepatic Encephalopathy Drug Sales Volume and Market Share by Application

8 India Hepatic Encephalopathy Drug (Volume, Value and Sales Price)
8.1 India Hepatic Encephalopathy Drug Sales and Value (2012-2017)
8.1.1 India Hepatic Encephalopathy Drug Sales and Growth Rate (2012-2017)
8.1.2 India Hepatic Encephalopathy Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Hepatic Encephalopathy Drug Sales Price Trend (2012-2017)
8.2 India Hepatic Encephalopathy Drug Sales Volume and Market Share by Players
8.3 India Hepatic Encephalopathy Drug Sales Volume and Market Share by Type
8.4 India Hepatic Encephalopathy Drug Sales Volume and Market Share by Application

9 Global Hepatic Encephalopathy Drug Players/Suppliers Profiles and Sales Data
9.1 Alfa Wassermann S.p.A
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Cosmo Pharmaceuticals S.p.A
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Horizon Pharma Plc
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Horizon Pharma Plc Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 KannaLife Sciences, Inc.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Ocera Therapeutics, Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Rebiotix Inc.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Rebiotix Inc. Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Spherium Biomed S.L.
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Umecrine Cognition AB
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Umecrine Cognition AB Hepatic Encephalopathy Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview

10 Hepatic Encephalopathy Drug Maufacturing Cost Analysis
10.1 Hepatic Encephalopathy Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Hepatic Encephalopathy Drug
10.3 Manufacturing Process Analysis of Hepatic Encephalopathy Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Hepatic Encephalopathy Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Hepatic Encephalopathy Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Hepatic Encephalopathy Drug Market Forecast (2017-2022)
14.1 Global Hepatic Encephalopathy Drug Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Hepatic Encephalopathy Drug Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Hepatic Encephalopathy Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Hepatic Encephalopathy Drug Price and Trend Forecast (2017-2022)
14.2 Global Hepatic Encephalopathy Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Hepatic Encephalopathy Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Hepatic Encephalopathy Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Hepatic Encephalopathy Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Hepatic Encephalopathy Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Hepatic Encephalopathy Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Hepatic Encephalopathy Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Hepatic Encephalopathy Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Hepatic Encephalopathy Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Hepatic Encephalopathy Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Hepatic Encephalopathy Drug Sales Forecast by Type (2017-2022)
14.3.2 Global Hepatic Encephalopathy Drug Revenue Forecast by Type (2017-2022)
14.3.3 Global Hepatic Encephalopathy Drug Price Forecast by Type (2017-2022)
14.4 Global Hepatic Encephalopathy Drug Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Hepatic Encephalopathy Drug
Figure Global Hepatic Encephalopathy Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Hepatic Encephalopathy Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure RBX-2660 Product Picture
Figure KLS-13019 Product Picture
Figure GR-3027 Product Picture
Figure SYNB-1020 Product Picture
Figure Others Product Picture
Figure Global Hepatic Encephalopathy Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Hepatic Encephalopathy Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Hepatic Encephalopathy Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Hepatic Encephalopathy Drug Sales Volume (K Pcs) (2012-2017)
Table Global Hepatic Encephalopathy Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Hepatic Encephalopathy Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Hepatic Encephalopathy Drug Sales Share by Players/Suppliers
Figure 2017 Hepatic Encephalopathy Drug Sales Share by Players/Suppliers
Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Hepatic Encephalopathy Drug Revenue Share by Players
Table 2017 Global Hepatic Encephalopathy Drug Revenue Share by Players
Table Global Hepatic Encephalopathy Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Hepatic Encephalopathy Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Hepatic Encephalopathy Drug by Type (2012-2017)
Figure Global Hepatic Encephalopathy Drug Sales Growth Rate by Type (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hepatic Encephalopathy Drug by Type (2012-2017)
Figure Global Hepatic Encephalopathy Drug Revenue Growth Rate by Type (2012-2017)
Table Global Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Hepatic Encephalopathy Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Hepatic Encephalopathy Drug by Region (2012-2017)
Figure Global Hepatic Encephalopathy Drug Sales Growth Rate by Region in 2016
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Hepatic Encephalopathy Drug by Region (2012-2017)
Figure Global Hepatic Encephalopathy Drug Revenue Growth Rate by Region in 2016
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Hepatic Encephalopathy Drug by Region (2012-2017)
Figure Global Hepatic Encephalopathy Drug Revenue Market Share by Region in 2016
Table Global Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Hepatic Encephalopathy Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Hepatic Encephalopathy Drug by Application (2012-2017)
Figure Global Hepatic Encephalopathy Drug Sales Market Share by Application (2012-2017)
Figure United States Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Hepatic Encephalopathy Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States Hepatic Encephalopathy Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Hepatic Encephalopathy Drug Sales Volume Market Share by Players in 2016
Table United States Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States Hepatic Encephalopathy Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Hepatic Encephalopathy Drug Sales Volume Market Share by Type in 2016
Table United States Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States Hepatic Encephalopathy Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Hepatic Encephalopathy Drug Sales Volume Market Share by Application in 2016
Figure China Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Hepatic Encephalopathy Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China Hepatic Encephalopathy Drug Sales Volume Market Share by Players (2012-2017)
Figure China Hepatic Encephalopathy Drug Sales Volume Market Share by Players in 2016
Table China Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Hepatic Encephalopathy Drug Sales Volume Market Share by Type (2012-2017)
Figure China Hepatic Encephalopathy Drug Sales Volume Market Share by Type in 2016
Table China Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China Hepatic Encephalopathy Drug Sales Volume Market Share by Application (2012-2017)
Figure China Hepatic Encephalopathy Drug Sales Volume Market Share by Application in 2016
Figure Europe Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Hepatic Encephalopathy Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Hepatic Encephalopathy Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Hepatic Encephalopathy Drug Sales Volume Market Share by Players in 2016
Table Europe Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Hepatic Encephalopathy Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Hepatic Encephalopathy Drug Sales Volume Market Share by Type in 2016
Table Europe Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Hepatic Encephalopathy Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Hepatic Encephalopathy Drug Sales Volume Market Share by Application in 2016
Figure Japan Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Hepatic Encephalopathy Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Hepatic Encephalopathy Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Hepatic Encephalopathy Drug Sales Volume Market Share by Players in 2016
Table Japan Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Hepatic Encephalopathy Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Hepatic Encephalopathy Drug Sales Volume Market Share by Type in 2016
Table Japan Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Hepatic Encephalopathy Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Hepatic Encephalopathy Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Hepatic Encephalopathy Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Hepatic Encephalopathy Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Hepatic Encephalopathy Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Hepatic Encephalopathy Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Hepatic Encephalopathy Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Hepatic Encephalopathy Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Hepatic Encephalopathy Drug Sales Volume Market Share by Application in 2016
Figure India Hepatic Encephalopathy Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Hepatic Encephalopathy Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India Hepatic Encephalopathy Drug Sales Volume Market Share by Players (2012-2017)
Figure India Hepatic Encephalopathy Drug Sales Volume Market Share by Players in 2016
Table India Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Hepatic Encephalopathy Drug Sales Volume Market Share by Type (2012-2017)
Figure India Hepatic Encephalopathy Drug Sales Volume Market Share by Type in 2016
Table India Hepatic Encephalopathy Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Hepatic Encephalopathy Drug Sales Volume Market Share by Application (2012-2017)
Figure India Hepatic Encephalopathy Drug Sales Volume Market Share by Application in 2016
Table Alfa Wassermann S.p.A Basic Information List
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales Growth Rate (2012-2017)
Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales Global Market Share (2012-2017
Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Revenue Global Market Share (2012-2017)
Table Cosmo Pharmaceuticals S.p.A Basic Information List
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales Growth Rate (2012-2017)
Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales Global Market Share (2012-2017
Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Revenue Global Market Share (2012-2017)
Table Horizon Pharma Plc Basic Information List
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Sales Growth Rate (2012-2017)
Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Sales Global Market Share (2012-2017
Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Revenue Global Market Share (2012-2017)
Table KannaLife Sciences, Inc. Basic Information List
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales Growth Rate (2012-2017)
Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales Global Market Share (2012-2017
Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Revenue Global Market Share (2012-2017)
Table Ocera Therapeutics, Inc. Basic Information List
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales Growth Rate (2012-2017)
Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales Global Market Share (2012-2017
Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Revenue Global Market Share (2012-2017)
Table Rebiotix Inc. Basic Information List
Table Rebiotix Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Rebiotix Inc. Hepatic Encephalopathy Drug Sales Growth Rate (2012-2017)
Figure Rebiotix Inc. Hepatic Encephalopathy Drug Sales Global Market Share (2012-2017
Figure Rebiotix Inc. Hepatic Encephalopathy Drug Revenue Global Market Share (2012-2017)
Table Spherium Biomed S.L. Basic Information List
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales Growth Rate (2012-2017)
Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales Global Market Share (2012-2017
Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Revenue Global Market Share (2012-2017)
Table Umecrine Cognition AB Basic Information List
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Sales Growth Rate (2012-2017)
Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Sales Global Market Share (2012-2017
Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatic Encephalopathy Drug
Figure Manufacturing Process Analysis of Hepatic Encephalopathy Drug
Figure Hepatic Encephalopathy Drug Industrial Chain Analysis
Table Raw Materials Sources of Hepatic Encephalopathy Drug Major Players in 2016
Table Major Buyers of Hepatic Encephalopathy Drug
Table Distributors/Traders List
Figure Global Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Hepatic Encephalopathy Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Hepatic Encephalopathy Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Hepatic Encephalopathy Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Hepatic Encephalopathy Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Hepatic Encephalopathy Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Hepatic Encephalopathy Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Hepatic Encephalopathy Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Hepatic Encephalopathy Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Hepatic Encephalopathy Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Hepatic Encephalopathy Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Hepatic Encephalopathy Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Hepatic Encephalopathy Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Hepatic Encephalopathy Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Hepatic Encephalopathy Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

肝性脳症薬

★調査レポート[世界の肝性脳症薬市場:販売動向2018] (コード:QYR8020832)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の肝性脳症薬市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆